Arm Holdings has seen a volatile year, rallying to record highs before a 35% pullback. Despite this, 24/7 Wall St. maintains a strong ‘BUY’ rating with a $344.98 price target, driven by Arm’s pivotal role in the agentic AI data center CPU market and robust fundamentals. While high valuation and litigation risks persist, the company’s strategic investments and strong customer demand for its upcoming AGI CPU position it for continued growth.
Arm Holdings (NASDAQ:ARM) has been a headline-grabbing stock throughout 2026, experiencing a meteoric rise from around $105 in January to an all-time high of $452.70 in June, only to see a significant portion of those gains evaporate.
With shares now hovering near $315, a crucial question arises for investors: Does the compelling AI CPU narrative still offer substantial growth, or has the period of easy returns concluded? Our proprietary analysis indicates further upside, albeit at a more measured pace than recent history suggests.
Our 24/7 Wall St. Price Target for Arm
The core of the Arm Holdings investment thesis lies in its potential to become the undisputed standard for CPU architecture within the burgeoning agentic AI data center ecosystem. Our dedicated 24/7 Wall St. price target for Arm is set at $344.98, which implies a respectable 9.42% upside from the current trading price of $315.28. We are issuing a 'BUY' recommendation with a strong confidence level of 90%.

| Metric | Value |
|---|---|
| Current Price | $315.28 |
| 24/7 Wall St. Price Target | $344.98 |
| Upside | 9.42% |
| Recommendation | BUY |
| Confidence Level | 90% |
A Dramatic Ascent and Retreat: From $105 to $452 and Back
Arm’s stock has delivered an impressive 188.43% year-to-date return and a 103.89% gain over the past year. However, the last month has been particularly challenging, with shares plummeting 21.71% over 30 days and 9.33% in the last week. The stock now sits a significant 35% below its 52-week peak of $452.70. This recent downturn was triggered by a combination of factors, including a broader slump across the semiconductor sector, a downgrade to 'Neutral' by New Street Research, and reports of executive insider selling.
Despite the volatile price action, Arm's underlying business fundamentals remain robust. The company reported Q4 FY2026 revenue of $1.49 billion, representing a strong 20.1% year-over-year increase, alongside non-GAAP EPS of $0.60, which comfortably surpassed consensus estimates. For the full fiscal year 2026, revenue reached $4.92 billion (+22.79%), marking a third consecutive year of over 20% growth. Investors are now keenly awaiting the next earnings report, scheduled for July 29, 2026.
The Bull Case: A Path to $448 and Beyond
Our bullish scenario projects a final price target of $448.25 for Arm, suggesting a compelling 42.17% return from current levels. The primary catalyst for this optimistic outlook is the impending launch of Arm AGI CPU, the company's first silicon designed specifically for data center production. Management has already signaled substantial customer demand, estimating over $2 billion in orders for fiscal years 2027-2028, and a massive addressable market—the data center CPU Total Addressable Market (TAM)—is expected to exceed $100 billion by 2030.
Leading tech giants like Meta, Google, NVIDIA, Microsoft, Oracle, and OpenAI are actively developing Arm-based silicon, solidifying the company's central role in the AI revolution. Adding to the bullish sentiment, several Wall Street analysts have recently raised their price targets, with TD Cowen targeting $475, UBS at $470, and Mizuho setting an ambitious $500, underpinned by projections of $15 billion in agentic AI CPU revenue by fiscal 2031.
Potential Headwinds: What Could Go Wrong
On the flip side, our bear case scenario anticipates a price of $268.49, implying a 14.84% loss. A significant concern remains Arm's valuation, which currently stands at a trailing P/E of 402 and a forward P/E of 154, indicating substantial future growth is already priced in. Non-GAAP operating margins have also seen some compression, moving from 52.8% to 49.1%, primarily due to a 43% surge in R&D spending to $1.911 billion. While bulls argue this is a strategic investment to capitalize on the agentic AI opportunity—a perspective supported by a 395.5% jump in FY2026 free cash flow—it introduces short-term pressure.
Other notable risks include the high-stakes Qualcomm/Nuvia trial slated for Q4 CY2026, the potential impact of 25% U.S. semiconductor tariffs, and an ongoing FTC antitrust investigation that was reported in May.
The Current Setup: Constructive Above $300, More Enticing Below
Our 24/7 Wall St. price target for Arm remains $344.98, maintaining our 'BUY' recommendation with 90% confidence. The bull thesis will gain further traction if the upcoming July 29 earnings report validates the Q1 FY2027 revenue guidance of $1.26 billion and if Arm continues to hold strong hyperscaler CPU market share near 50%. Conversely, the thesis could weaken if margins continue to compress without a clear inflection point in royalty rates, or if the Qualcomm ruling is unfavorable to Arm. At its current valuation, we believe the risk/reward profile is favorably tilted toward the upside.
Here are our model's projections for where Arm's stock could trade in the coming years, contingent on the expansion of Armv9 royalty rates and management's roadmap for AGI CPU adoption:
| Year | 24/7 Wall St. Price Target |
|---|---|
| 2026 | $344.98 |
| 2027 | $378 |
| 2028 | $405 |
| 2029 | $425 |
| 2030 | $442.80 |
These forward-looking projections hinge on Arm's continued successful execution of its AGI CPU roadmap and securing key hyperscaler design wins. Significant additional upside could materialize if Meta’s personal superintelligence rollout achieves widespread adoption among its 3 billion-plus user base. Downside risks, however, are primarily tied to the outcomes of various litigations and evolving China export policies.
